152 related articles for article (PubMed ID: 32131034)
1. The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer's disease.
Sang Z; Wang K; Shi J; Liu W; Cheng X; Zhu G; Wang Y; Zhao Y; Qiao Z; Wu A; Tan Z
Eur J Med Chem; 2020 Apr; 192():112180. PubMed ID: 32131034
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and evaluation of dual-target inhibitors for the treatment of Alzheimer's disease.
Zhai J; Hao C; Wang X; Cao Y; Pan Y; Zhou M; Sun J; Li C
Arch Pharm (Weinheim); 2024 May; 357(5):e2300693. PubMed ID: 38332316
[TBL] [Abstract][Full Text] [Related]
3. Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's drug candidates.
Piemontese L; Tomás D; Hiremathad A; Capriati V; Candeias E; Cardoso SM; Chaves S; Santos MA
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1212-1224. PubMed ID: 30160188
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and In Vitro Evaluation of Hydroxybenzimidazole-Donepezil Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease.
Chaves S; Resta S; Rinaldo F; Costa M; Josselin R; Gwizdala K; Piemontese L; Capriati V; Pereira-Santos AR; Cardoso SM; Santos MA
Molecules; 2020 Feb; 25(4):. PubMed ID: 32098407
[TBL] [Abstract][Full Text] [Related]
5. Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer's disease therapy.
Pachón-Angona I; Refouvelet B; Andrýs R; Martin H; Luzet V; Iriepa I; Moraleda I; Diez-Iriepa D; Oset-Gasque MJ; Marco-Contelles J; Musilek K; Ismaili L
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):479-489. PubMed ID: 30712420
[TBL] [Abstract][Full Text] [Related]
6. Discovery of 4-benzylpiperazinequinoline BChE inhibitor that suppresses neuroinflammation for the treatment of Alzheimer's disease.
Chen Y; Zhang W; Li Q; Xie H; Xing S; Lu X; Lyu W; Xiong B; Wang Y; Qu W; Liu W; Chi H; Zhang X; Feng F; Sun H
Eur J Med Chem; 2024 Jun; 272():116463. PubMed ID: 38704944
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy.
Waiker DK; Verma A; Gajendra TA; Namrata ; Roy A; Kumar P; Trigun SK; Srikrishna S; Krishnamurthy S; Davisson VJ; Shrivastava SK
Eur J Med Chem; 2024 May; 271():116409. PubMed ID: 38663285
[TBL] [Abstract][Full Text] [Related]
8. Lead optimization based design, synthesis, and pharmacological evaluation of quinazoline derivatives as multi-targeting agents for Alzheimer's disease treatment.
Verma A; Waiker DK; Singh N; Singh A; Saraf P; Bhardwaj B; Kumar P; Krishnamurthy S; Srikrishna S; Shrivastava SK
Eur J Med Chem; 2024 May; 271():116450. PubMed ID: 38701714
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of Shenghui decoction via inhibition of the JNK/p38 MAPK signaling pathway in an AlCl
Lu H; Tan A; Zhang Y; Chen Y; Ran S; Wang P
J Ethnopharmacol; 2024 Jun; 328():117993. PubMed ID: 38423408
[TBL] [Abstract][Full Text] [Related]
10. Claulansine F-Donepezil Hybrids as Anti-Alzheimer's Disease Agents with Cholinergic, Free-Radical Scavenging, and Neuroprotective Activities.
Zang Y; Liu K; Wang W; Li C; Ma J; Yang J; Chen X; Wang X; Zhang D
Molecules; 2021 Feb; 26(5):. PubMed ID: 33671020
[TBL] [Abstract][Full Text] [Related]
11. Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation.
Markowicz-Piasecka M; Huttunen KM; Sikora J
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1309-1322. PubMed ID: 30251898
[TBL] [Abstract][Full Text] [Related]
12. Combining Chalcones with Donepezil to Inhibit Both Cholinesterases and Aβ Fibril Assembly.
Thamban Chandrika N; Fosso MY; Tsodikov OV; LeVine Iii H; Garneau-Tsodikova S
Molecules; 2019 Dec; 25(1):. PubMed ID: 31878304
[TBL] [Abstract][Full Text] [Related]
13. Development of multi-targetable chalcone derivatives bearing N-aryl piperazine moiety for the treatment of Alzheimer's disease.
Bajad NG; Singh RB; T A G; Gutti G; Kumar A; Krishnamurthy S; Singh SK
Bioorg Chem; 2024 Feb; 143():107082. PubMed ID: 38199142
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 7-O-1, 2, 3-triazole hesperetin derivatives as multi-target-directed ligands against Alzheimer's disease.
Wang M; Fang L; Liu T; Chen X; Zheng Y; Zhang Y; Chen S; Li Z
Chem Biol Interact; 2021 Jun; 342():109489. PubMed ID: 33905740
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and evaluation of novel
Zhu G; Bai P; Wang K; Mi J; Yang J; Hu J; Ban Y; Xu R; Chen R; Wang C; Tang L; Sang Z
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1375-1388. PubMed ID: 35549612
[TBL] [Abstract][Full Text] [Related]
16. Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer's Disease Agents.
Poliseno V; Chaves S; Brunetti L; Loiodice F; Carrieri A; Laghezza A; Tortorella P; Magalhães JD; Cardoso SM; Santos MA; Piemontese L
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33467709
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of new multi-target scutellarein hybrids for treatment of Alzheimer's disease.
Luo K; Chen J; Li H; Wu D; Du Y; Zhao S; Liu T; Li L; Dai Z; Li Y; Zhao Y; Tang L; Fu X
Bioorg Chem; 2023 Sep; 138():106596. PubMed ID: 37186997
[TBL] [Abstract][Full Text] [Related]
18. Novel harmine derivatives as potent acetylcholinesterase and amyloid beta aggregation dual inhibitors for management of Alzheimer's disease.
Du H; Song J; Ma F; Gao H; Zhao X; Mao R; He X; Yan Y
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2281893. PubMed ID: 37965884
[TBL] [Abstract][Full Text] [Related]
19. Discovery of new acetylcholinesterase inhibitors for Alzheimer's disease: virtual screening and
David B; Schneider P; Schäfer P; Pietruszka J; Gohlke H
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):491-496. PubMed ID: 33478277
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of Halogen-Substituted novel α-Ketoamides as potential protein aggregation modulators in Alzheimer's disease.
Das B; Tk Baidya A; Chakrabarti S; Chouhan D; Thakur B; Darreh-Shori T; Chen G; Tiwari V; Kumar R
Bioorg Chem; 2024 Jun; 147():107373. PubMed ID: 38653149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
